| Literature DB >> 31847243 |
Mariam Jarouche1, Harsha Suresh2, James Hennell1, Shaun Sullivan1, Samiuela Lee3, Swastika Singh1, Declan Power2, Cindy Xu4, Cheang Khoo4.
Abstract
Lycium (also known as Goji berry) is used in traditional Chinese medicine (TCM) with claimed benefits, including eye and liver protection, immune system fortification and blood glucose control. The commercially available product comes from either the L. barbarum or L. chinense species, with the former dominating the marketplace due to its better taste profile. The main objective of this study was to develop a validated LC-ESI-MS/MS method to quantify multiple key bio-active analytes in commercially available Lycium berries and to qualitatively assess these samples using a principal component analysis (PCA). A LC-ESI-MS/MS method for the quantitation of seven analytes selected using the Herbal Chemical Marker Ranking System (Herb MaRS) was developed. The Herb MaRS ranking system considered bioavailability, bioactivity and physiological action of each target analyte, its intended use and the commercial availability of an analytical standard. After method optimization combining high resolving power with selective detection, seven analytes were quantified and the Lycium samples were quantitatively profiled. Chromatographic spectra were also obtained using longer run-time LC-UV and GC-MS methods in order to qualitatively assess the samples using a principal component analysis (PCA). The result of the method validation procedure was a 15.5 min LC-ESI-MS/MS method developed for the quantification of seven analytes in commercial Lycium samples. Wide variation in analyte concentration was observed with the following results (analyte range in mg/g): rutin, 16.1-49.2; narcissin, 0.37-1.65; nictoflorin, 0.26-0.78; coumaric acid, 6.84-12.2; scopoletin, 0.33-2.61; caffeic acid, 0.08-0.32; chlorogenic acid, 1.1-9.12. The quantitative results for the L. barbarum and L. chinense species samples indicate that they cannot be differentiated based on the bio-actives tested. A qualitative assessment using PCA generated from un-targeted LC-UV and GC-MS phytochemical spectra led to the same conclusion. The un-targeted quantitative and qualitative phytochemical profiling indicates that commercial L. barbarum and L. chinense cannot be distinguished using chemical analytical methods. Genetic fingerprinting and pharmacological testing may be needed to ensure the efficacy of commercial Lycium in order to validate label claims.Entities:
Keywords: Chemometrics; Herb MaRS; LC-MS; Lycium; PCA
Year: 2019 PMID: 31847243 PMCID: PMC6963852 DOI: 10.3390/plants8120604
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Structures of the seven target analytes monitored in Lycium.
| Compound | Chemical Structure |
|---|---|
| Rutin |
|
| Narcissin |
|
| Nictoflorin |
|
| Coumaric acid |
|
| Scopoletin |
|
| Caffeic acid |
|
| Chlorogenic acid |
|
Reported pharmacological activities of target analytes in Lycium.
| Analyte [References] | Reported Activity | Herb Mars Ranking a,b |
|---|---|---|
| Rutin [ | Anti-hepatotoxic, anti-oxidant, cAMP-phosphodiesterase-inhibitor, vasopressor, vasodilator, anti-inflammatory, cytoprotective | 5 |
| Narcissin [ | Anti-inflammatory, anti-oxidant, hepatoprotective | 4 |
| Nictoflorin [ | Anti-hepatotoxic, anti-oxidant, iNOS-Inhibitor, cAMP-phosphodiesterase-inhibitor, TNF-alpha-inhibitor, neuroprotective | 4 |
| Coumaric acid [ | Anti-hepatotoxic, anti-oxidant | 3 |
| Scopoletin [ | Anti-hepatotoxic, anti-oxidant | 3 |
| Caffeic acid [ | Anti-oxidant, anti-inflammatory, anti-hepatotoxic, hepatotropic | 2 |
| Chlorogenic acid [ | Hepatotropic, anti-inflammatory | 2 |
a: Herbal Chemical Marker Ranking System (5). b: The ranking score ranges from 0 to 5, with 0 being the least and 5 being the most suitable.
Mobile phase gradient program for the LC-ESI-MS/MS method.
| Time (min) | Water (with 0.1 % | Acetonitrile % |
|---|---|---|
| Initial | 80 | 20 |
| 1.0 | 75 | 25 |
| 6.0 | 55 | 45 |
| 11.0 | 35 | 65 |
| 13.0 | 25 | 75 |
| 15.0 | 80 | 20 |
| 15.5 | 80 | 20 |
LC-ESI-MS/MS monitoring conditions.
| Analyte | ESI Polarity | Precursor | Product | Respective Voltages (V) | Dwell Time (s) |
|---|---|---|---|---|---|
| Rutin | - | [M-H]− = 609 | 255, 271, 300 | 50, 62, 40 | 0.016 |
| Narcissin | - | [M-H]− = 623 | 299, 315 | 48, 30 | 0.017 |
| Nictoflorin | - | [M-H]− = 593 | 255, 284 | 54, 34 | 0.017 |
| Coumaric acid | - | [M-H]− = 164 | 93, 120 | 12, 26 | 0.016 |
| Scopoletin | - | [M-H]− = 191 | 103, 176 | 24, 16 | 0.016 |
| Caffeic acid * | - | [M-H]− = 179 | 135 | 15 | 0.195 |
| Chlorogenic acid | - | [M-H]− = 353 | 93, 191 | 50, 50 | 0.095 |
*: Only one product m/z ion was observed for caffeic acid.
Figure 1Representative LC-ESI-MS/MS chromatogram of the extract of sample LB7 containing (1) Rutin, (2) Narcissin, (3) Nictoflorin, (4) Coumaric acid, (5) Scopoletin, (6) Caffeic acid and (7) Chlorogenic acid.
Analyte recoveries.
| Analyte | Spike Levels a,c,d | Cumulative Results | ||||||
|---|---|---|---|---|---|---|---|---|
| 50% | 100% | 200% | ||||||
| Recovery % | RSD % | Recovery % | RSD % | Recovery % | RSD % | Average Recovery b % | RSD % | |
| Rutin | 93.1 | 3.7 | 90.2 | 7.9 | 89.1 | 8.6 | 90.8 | 6.7 |
| Narcissin | 105.6 | 3.4 | 101.7 | 1.7 | 100.5 | 2.5 | 102.6 | 2.8 |
| Nictoflorin | 92.2 | 3.8 | 94.5 | 2.9 | 95.2 | 2.5 | 93.9 | 3.1 |
| Coumaric acid | 98.4 | 7.5 | 88.6 | 9.3 | 102.0 | 3.8 | 96.3 | 6.8 |
| Scopoletin | 89.6 | 7.0 | 95.3 | 5.5 | 91.2 | 3.3 | 92.0 | 5.3 |
| Caffeic acid | 89.9 | 7.1 | 110.8 | 9.5 | 113.7 | 4.2 | 104.8 | 1.9 |
| Chlorogenic acid | 101 | 9.2 | 112.8 | 8.2 | 114.3 | 7.4 | 109.4 | 4.5 |
a: % Recovery ± % RSD calculated from n = 7 extractions and injected in triplicate. b: Average recovery of all three spiking levels ± % RSD. c: LOD was 0.005 mg/g. d: LOD was 0.003 mg/g.
Precision of quantitation.
| Analyte | Linearity (R2) | Linear Range (µg/mL) | Precision a | LOD (mg/g) b | LOQ (mg/g) c | |
|---|---|---|---|---|---|---|
| Amount (mg/g) (± % RSD) | RT (min) (± % RSD) | |||||
| Rutin | 0.9992 | 57.0-1140.0 | 34.8 (4.3) | 9.37 (0.02) | 0.42 | 1.4 |
| Narcissin | 0.9995 | 3.0-60.0 | 1.65 (2.8) | 10.30 (0.01) | 0.13 | 0.4 |
| Nictoflorin | 0.9994 | 0.6-11.6 | 0.77 (5.9) | 10.20 (0.01) | 0.14 | 0.47 |
| Coumaric acid | 0.9991 | 4.5-89.4 | 10.3 (6.9) | 8.30 (0.02) | 0.25 | 0.84 |
| Scopoletin | 0.9995 | 0.9-17.4 | 1.68 (4.3) | 7.75 (0.03) | 0.06 | 0.20 |
| Caffeic acid | 0.9995 | 0.1-1.6 | 0.11 (9.3) | 6.35 (0.01) | 0.04 | 0.12 |
| Chlorogenic acid | 0.9991 | 2.0-39.6 | 4.19 (5.9) | 5.21 (0.01) | 0.74 | 2.47 |
a: Average and RSD calculated from n = 7 extraction replicates injected in triplicate. b: Limit of detection (LOD) is three times the standard deviation (SD) for each analyte in LB7. c: Limit of detection (LOQ) is ten times the standard deviation (SD) for each analyte in LB7.
Identity confirmation of the analytes.
| Analyte | Relative Intensity | Tolerances | ||||
|---|---|---|---|---|---|---|
|
| Standard | Sample | Relative Difference (± %) a | Permitted Tolerance (± %) b | Pass/Fail | |
| Rutin | 300 | 100 | 100 | - | 20 | Pass |
| 271 | 61 | 60 | 1.6 | 20 | Pass | |
| 255 | 31 | 30 | 3.2 | 25 | Pass | |
| Narcissin | 315 | 100 | 100 | - | 20 | Pass |
| 299 | 61 | 53 | 14 | 20 | Pass | |
| Nictoflorin | 284 | 100 | 100 | - | 25 | Pass |
| 255 | 86 | 73 | 16 | 25 | Pass | |
| Coumaric acid | 120 | 100 | 100 | - | 25 | Pass |
| 93 | 29 | 28 | 3.5 | 25 | Pass | |
| Scopoletin | 176 | 100 | 100 | - | 25 | Pass |
| 103 | 40 | 36 | 10 | 25 | Pass | |
| Caffeic acid | 135 | 100 | 100 | - | 25 | Pass |
| Chlorogenic acid | 191 | 100 | 100 | - | 25 | Pass |
| 93 | 50 | 37 | 26 | 25 | Fail | |
a: Relative difference = [Intensity of sample—intensity of pure standard)/(intensity of pure standard)] × 100. b: Maximum permitted tolerance from the European Commission Directorate for Agricultural guidelines [43].
Concentrations of target analytes.
| Analyte Concentrations in Sample (mg/g) (± % RSD) a | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sample d | Rutin | Narcissin | Nictoflorin | Coumaric Acid | Scopoletin | Caffeic Acid | Chlorogenic Acid | Total Concentration |
| LB1 | 16.1 (9.3) | 0.37 (3.0) | 0.37 (8.5) | 6.84 (4.5) | 0.77 (6.7) | 0.18 (3.8) | 3.71 (5.4) | 28.4 |
| LB2 | 43.1 (8.5) | 0.56 (4.8) | 0.26 (1.9) | 10.3 (7.0) | 0.33 (9.0) | <LOD | <LOD | 54.6 |
| LB3 | 19.5 (3.3) | 0.94 (7.5) | 0.43 (4.9) | 10.6 (4.1) | 1.59 (3.8) | 0.08 (9.4) | 1.44 (6.6) | 34.4 |
| LB4 | 19.1 (3.8) | 1.23 (6.8) | 0.58 (7.8) | 10.2 (5.3) | 1.32 (6.9) | <LOD | 1.11 (5.4) | 33.5 |
| LB5 | 48.2 (6.2) | 1.46 (5.2) | 0.7 (7.8) | 12.1 (5.7) | 0.78 (6.7) | 0.15 (7.1) | 3.71 (5.3) | 67.3 |
| LB6 | 23.1 (2.8) | 0.62 (6.5) | 0.41 (5.8) | 11.2 (4.1) | 1.19 (6.0) | 0.24 (7.0) | 4.12 (5.8) | 40.7 |
| LB7 c | 34.8 (4.3) | 1.65 (2.8) | 0.77 (5.9) | 10.3 (6.9) | 1.68 (4.3) | 0.11 (9.3) | 4.19 (5.9) | 53.4 |
| LB8 | 49.2 (3.3) | 1.43 (6.6) | 0.67 (4.6) | 12.2 (5.9) | 2.17 (6.9) | 0.15 (7.0) | 7.15 (9.0) | 72.9 |
| LC1 | 25.3 (2.5) | 1.23 (4.4) | 0.43 (8.0) | 9.78 (5.8) | 2.59 (6.4) | 0.09 (6.1) | 2.91 (8.3) | 42.1 |
| LC2 | 21.5 (3.6) | 0.98 (2.6) | 0.51 (3.7) | 10.2 (5.6) | 1.60 (5.5) | 0.16 (4.3) | 4.24 (7.2) | 39.2 |
| LC3 | 35.1 (6.7) | 1.11 (3.5) | 0.44 (3.6) | 8.61 (7.1) | 2.36 (5.1) | 0.32 (6.4) | 9.12 (7.3) | 57.0 |
| LC4 | 33.1 (4.0) | 1.25 (3.4) | 0.63 (4.9) | 10.2 (7.0) | 2.61 (4.7) | 0.18 (6.7) | 5.17 (5.3) | 53.1 |
| Mean (mg/g) | 30.7 | 1.07 | 0.52 | 10.2 | 1.58 | 0.17 | 4.26 | 48.1 |
| Fold variation b | 3.1 | 3.9 | 6.0 | 1.8 | 7.8 | 4.3 | 7.3 | N/A |
a: Average calculated from n = 7 replicates ± % RSD. b: Fold variation = (highest concentration)/(lowest concentration), (
Figure 2LC-UV spectra PCA score plot for the L. barbarum and L. chinense samples.
Figure 3GC-MS spectra PCA score plot for the L. barbarum and L. chinense samples.